Piramal Pharma Limited intimated availability of its Q4 FY26 earnings call audio recording on the company website.
The conference call was held on 29th April 2026 to discuss audited standalone and consolidated financial results.
The disclosure is a regulatory compliance filing pursuant to SEBI LODR Regulations.